South Florida Widow Files Xarelto Lawsuit Alleging Drug Caused Her Husband’s Fatal Bleed

April 28, 2016 – – BloodThinnerHelp.com reports on the details of another lawsuit which was filed against Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation) referencing their new-generation blood-thinning drug Xarelto. The plaintiff in this case alleges that Xarelto use caused the death of her husband. The widow has filed a wrongful death suit which was initially listed under case number 9:14-cv-80831 in a Southern Florida court but was later transferred to the Eastern District of Louisiana to be consolidated with thousands of other similar lawsuits forming multidistrict litigation No. 2592. The MDL is being overseen at this time by the Honorable Judge Eldon Fallon.

Further details from within the lawsuit state that the widow claims that Xarelto manufacturers neglected to properly warn medical professionals and patients about potentially serious risks surrounding their product, such as sudden bleeding episodes and other adverse events she now connects to use of their product. The widow alleges that the anticoagulant caused her husband’s death, which happened when he suffered from an unexpected and uncontrollable internal bleeding event. Due to the Xarelto in his system, the woman reports, doctors were unable to clot his blood.

The woman goes on to explain that her husband was given a prescription for Xarelto as a treatment for his atrial fibrillation condition. The drug was intended to stop him from experiencing strokes, however, while the man was taking the drug, he instead suffered a subdural hemorrhage (or brain bleed), which caused him to ultimately pass away after doctors could not stop the bleed.

Unfortunately, this widow is not alone in her lawsuit claims. In just five year’s time, Xarelto has become the subject of over 3,400 lawsuits which have been formed into two main groupings. Over 2,800 federally-filed lawsuits have been transferred by the JPML to form MDL 2592 in Eastern Louisiana while more than 620 others have been formed into a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania. Involved plaintiffs share strikingly similar allegations that the drug places users at increased risk of severe and potentially life-threatening bleeding events.

As those involved anxiously await their day at trial, Attorney Joseph Osborne is working to help other patients who have used Xarelto and who believe the drug has negatively impacted their health. He hopes to ensure that all affected patients will be provided with the important opportunity to investigate their legal rights in the matter, as they may be entitled to significant compensation. To assist those wishing to further explore their options at this time, Attorney Osborne is offering complimentary legal consultations for qualified parties.

To request additional information, or to ask questions, contact Attorney Joseph Osborne at your convenience by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009653